@article{93efef7cb9ca4e3fa3364e380f823396,
title = "FDA public workshop summary: Advancing animal models for antibacterial drug development",
abstract = "The U.S. Food and Drug Administration (FDA) hosted a public workshop entitled “Advancing Animal Models for Antibacterial Drug Development” on 5 March 2020. The workshop mainly focused on models of pneumonia caused by Pseudomonas aeruginosa and Acinetobacter baumannii. The program included discussions from academic investigators, industry, and U.S. government scientists. The potential use of mouse, rabbit, and pig models for antibacterial drug development was presented and discussed.",
keywords = "Animal models, Antibacterial, Antibiotics, Drug development, FDA, Humanized dose, Pneumonia, Regulatory, Workshop",
author = "Byrne, {James M.} and Ursula Waack and Weinstein, {Edward A.} and Abhay Joshi and Shurland, {Simone M.} and Dmitri Iarikov and Bulitta, {J{\"u}rgen B.} and Diep, {Binh An} and Tina Guina and Hope, {William W.} and Lawrenz, {Matthew B.} and Lepak, {Alexander J.} and Luna, {Brian M.} and Lynn Miesel and Phipps, {Andrew J.} and Walsh, {Thomas J.} and William Weiss and Thushi Amini and Farley, {John J.}",
note = "Funding Information: This project was supported in part by an appointment to the Research Participation Program at the Office of Infectious Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA. Publisher Copyright: {\textcopyright} 2020 American Society for Microbiology. All Rights Reserved.",
year = "2021",
month = jan,
doi = "10.1128/AAC.01983-20",
language = "English",
volume = "65",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",
}